Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in NSCLC Patients Activating EGFR Mutations
Clinical trial NCT02759614 · COMPLETED
Trial details
- NCT number
- NCT02759614
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-06-01
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.